Healthcare Triangle Secures $1.63M Through Strategic Warrant Exercise

Healthcare Triangle, Inc. (Nasdaq: HCTI), a prominent digital transformation leader for healthcare and life sciences organizations, has executed significant warrant exercise agreements with accredited and institutional investors that will generate approximately $1.63 million in immediate capital. The Pleasanton, California-based company secured this funding through a strategic transaction where existing warrant holders exercised their rights to purchase 812,775 shares at a reduced price of $2.00 per share, down substantially from the original $20.92 exercise price. In return for this immediate cash infusion, investors received new warrants granting them the right to purchase an additional 812,775 shares at $3.00 per share once stockholder approval is obtained, creating a compelling incentive structure that benefits both the company and its financial backers.

The transaction, facilitated through NEWMEDIAWIRE distribution channels and managed by WallachBeth Capital as the sole placement agent, represents a sophisticated financial maneuver designed to strengthen Healthcare Triangle's balance sheet while maintaining investor participation. The new warrants feature a five-year expiration timeline from the date of stockholder approval, providing long-term investment opportunities for participating institutions. This capital raise occurs as Healthcare Triangle continues to expand its certified digital solutions portfolio, including their HITRUST-certified CloudEz™ and DataEz™ platforms that serve hospitals, health systems, payers, and pharmaceutical companies seeking enhanced data security and cloud transformation capabilities.

Healthcare Triangle's strategic positioning in the highly regulated healthcare technology space makes this capital infusion particularly significant, as the company specializes in helping healthcare organizations improve outcomes through advanced data utilization and digital transformation services. The immediate $1.63 million in gross proceeds, before accounting for placement fees and offering expenses, will support the company's mission of enabling healthcare progress through breakthrough technology and industry expertise. This financial reinforcement comes at a time when healthcare organizations increasingly rely on certified digital platforms to navigate complex regulatory requirements while optimizing clinical and business performance in an evolving healthcare landscape.